Effect of estrogen and progestin replacement on arterial stiffness indices in postmenopausal women

A. Scuteri, E. G. Lakatta, A. J G Bos, J. L. Fleg

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Our objectives were to investigate whether long-term estrogen replacement therapy (ERT) is associated with a reduction in age-associated increases in arterial stiffness and blood pressure (BP), and whether the addition of progestin modifies the effects of estrogen. ERT has been found to have beneficial effects on cardiovascular risk. There are few data, however, delineating the effects of ERT on BP and arterial stiffness, and their age-associated changes. BP and aorto-femoral pulse wave velocity (PWV) were measured in 134 post-menopausal volunteers, aged 51 to 90 years, from the Baltimore Longitudinal Study of Aging, screened to exclude clinical and occult cardiovascular disease, and classified as ERT non-users (N=57) or ERT users (N=77). The latter group was further substratified according to the use of estrogen alone (N=32) or a combination of estrogen and progestins (N=45). ERT users showed similar body habitus, physical activity, and plasma lipids compared to non-ERT users. ERT was associated with an average 9.8 mmHg lower systolic BP (p130 mmHg, the combination of ERT and progestins predicted a higher PWV than ERT alone. In conclusion, ERT in postmenopausal women can beneficially affect the vascular system, by reducing BP and the age-associated increase in arterial stiffness. The addition of progestins to ERT may reduce these beneficial effects.

Original languageEnglish
Pages (from-to)122-130
Number of pages9
JournalAging clinical and experimental research
Volume13
Issue number2
Publication statusPublished - 2001

Fingerprint

Vascular Stiffness
Estrogen Replacement Therapy
Progestins
Blood Pressure
Estrogens
Pulse Wave Analysis
Baltimore
Thigh
Blood Vessels
Longitudinal Studies
Volunteers
Arterial Pressure
Cardiovascular Diseases
Exercise

Keywords

  • Arterial stiffness
  • Blood pressure
  • Estrogen replacement
  • Menopause
  • Progestin

ASJC Scopus subject areas

  • Ageing

Cite this

Effect of estrogen and progestin replacement on arterial stiffness indices in postmenopausal women. / Scuteri, A.; Lakatta, E. G.; Bos, A. J G; Fleg, J. L.

In: Aging clinical and experimental research, Vol. 13, No. 2, 2001, p. 122-130.

Research output: Contribution to journalArticle

Scuteri, A. ; Lakatta, E. G. ; Bos, A. J G ; Fleg, J. L. / Effect of estrogen and progestin replacement on arterial stiffness indices in postmenopausal women. In: Aging clinical and experimental research. 2001 ; Vol. 13, No. 2. pp. 122-130.
@article{62dc32e2c9454257bed5582632b9977e,
title = "Effect of estrogen and progestin replacement on arterial stiffness indices in postmenopausal women",
abstract = "Our objectives were to investigate whether long-term estrogen replacement therapy (ERT) is associated with a reduction in age-associated increases in arterial stiffness and blood pressure (BP), and whether the addition of progestin modifies the effects of estrogen. ERT has been found to have beneficial effects on cardiovascular risk. There are few data, however, delineating the effects of ERT on BP and arterial stiffness, and their age-associated changes. BP and aorto-femoral pulse wave velocity (PWV) were measured in 134 post-menopausal volunteers, aged 51 to 90 years, from the Baltimore Longitudinal Study of Aging, screened to exclude clinical and occult cardiovascular disease, and classified as ERT non-users (N=57) or ERT users (N=77). The latter group was further substratified according to the use of estrogen alone (N=32) or a combination of estrogen and progestins (N=45). ERT users showed similar body habitus, physical activity, and plasma lipids compared to non-ERT users. ERT was associated with an average 9.8 mmHg lower systolic BP (p130 mmHg, the combination of ERT and progestins predicted a higher PWV than ERT alone. In conclusion, ERT in postmenopausal women can beneficially affect the vascular system, by reducing BP and the age-associated increase in arterial stiffness. The addition of progestins to ERT may reduce these beneficial effects.",
keywords = "Arterial stiffness, Blood pressure, Estrogen replacement, Menopause, Progestin",
author = "A. Scuteri and Lakatta, {E. G.} and Bos, {A. J G} and Fleg, {J. L.}",
year = "2001",
language = "English",
volume = "13",
pages = "122--130",
journal = "Aging clinical and experimental research",
issn = "1594-0667",
publisher = "Springer International Publishing AG",
number = "2",

}

TY - JOUR

T1 - Effect of estrogen and progestin replacement on arterial stiffness indices in postmenopausal women

AU - Scuteri, A.

AU - Lakatta, E. G.

AU - Bos, A. J G

AU - Fleg, J. L.

PY - 2001

Y1 - 2001

N2 - Our objectives were to investigate whether long-term estrogen replacement therapy (ERT) is associated with a reduction in age-associated increases in arterial stiffness and blood pressure (BP), and whether the addition of progestin modifies the effects of estrogen. ERT has been found to have beneficial effects on cardiovascular risk. There are few data, however, delineating the effects of ERT on BP and arterial stiffness, and their age-associated changes. BP and aorto-femoral pulse wave velocity (PWV) were measured in 134 post-menopausal volunteers, aged 51 to 90 years, from the Baltimore Longitudinal Study of Aging, screened to exclude clinical and occult cardiovascular disease, and classified as ERT non-users (N=57) or ERT users (N=77). The latter group was further substratified according to the use of estrogen alone (N=32) or a combination of estrogen and progestins (N=45). ERT users showed similar body habitus, physical activity, and plasma lipids compared to non-ERT users. ERT was associated with an average 9.8 mmHg lower systolic BP (p130 mmHg, the combination of ERT and progestins predicted a higher PWV than ERT alone. In conclusion, ERT in postmenopausal women can beneficially affect the vascular system, by reducing BP and the age-associated increase in arterial stiffness. The addition of progestins to ERT may reduce these beneficial effects.

AB - Our objectives were to investigate whether long-term estrogen replacement therapy (ERT) is associated with a reduction in age-associated increases in arterial stiffness and blood pressure (BP), and whether the addition of progestin modifies the effects of estrogen. ERT has been found to have beneficial effects on cardiovascular risk. There are few data, however, delineating the effects of ERT on BP and arterial stiffness, and their age-associated changes. BP and aorto-femoral pulse wave velocity (PWV) were measured in 134 post-menopausal volunteers, aged 51 to 90 years, from the Baltimore Longitudinal Study of Aging, screened to exclude clinical and occult cardiovascular disease, and classified as ERT non-users (N=57) or ERT users (N=77). The latter group was further substratified according to the use of estrogen alone (N=32) or a combination of estrogen and progestins (N=45). ERT users showed similar body habitus, physical activity, and plasma lipids compared to non-ERT users. ERT was associated with an average 9.8 mmHg lower systolic BP (p130 mmHg, the combination of ERT and progestins predicted a higher PWV than ERT alone. In conclusion, ERT in postmenopausal women can beneficially affect the vascular system, by reducing BP and the age-associated increase in arterial stiffness. The addition of progestins to ERT may reduce these beneficial effects.

KW - Arterial stiffness

KW - Blood pressure

KW - Estrogen replacement

KW - Menopause

KW - Progestin

UR - http://www.scopus.com/inward/record.url?scp=0034981603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034981603&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 122

EP - 130

JO - Aging clinical and experimental research

JF - Aging clinical and experimental research

SN - 1594-0667

IS - 2

ER -